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anglais
Lipid nanocapsules (LNCs) have demonstrated great potential for the oral delivery of
drugs having very limited oral bioavailability (BCS class II, III and IV molecules). It
has been shown previously that orally-administered LNCs can permeate through
mucus, increase drug absorption by the epithelial tissue, and finally, increase drug
bioavailability. However, even if transport mechanisms through mucus and the
intestinal barrier have already been clarified, the preservation of particle integrity is
still not known. The aim of the present work is to study in vitro the fate of LNCs after
their transportation across an intestinal epithelium model (Caco-2 cell model). For
this, two complementary techniques were employed: Förster Resonance Energy
Transfer (FRET) and Nanoparticle Tracking Analysis (NTA). Results showed, after 2 h,
the presence of nanoparticles in the basolateral side of the cell layer and a
measurable FRET signal. This provides very good evidence for the transcellular intact
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